Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry

BackgroundSulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms.ResultsAnalysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST.ConclusionsThis study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers.

[1]  Richard M Caprioli,et al.  A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer* , 2006, Molecular & Cellular Proteomics.

[2]  Cheng Luo,et al.  Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.

[3]  Y. Kozutsumi,et al.  Dihydroceramide:sphinganine C-4-hydroxylation requires Des2 hydroxylase and the membrane form of cytochrome b5. , 2006, The Biochemical journal.

[4]  J. F. Harris,et al.  Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells , 1990, Clinical & Experimental Metastasis.

[5]  Michelle L. Reyzer,et al.  Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. , 2003, Journal of mass spectrometry : JMS.

[6]  S. Hakomori,et al.  Glycolipids of tumor cell membrane. , 1973, Advances in cancer research.

[7]  L. Rome,et al.  Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. , 2000, Biochimica et biophysica acta.

[8]  S. Datta,et al.  Gene expression profiling of epithelial ovarian tumours correlated with malignant potential , 2004, Molecular Cancer.

[9]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[10]  J. A. Fernández,et al.  Profiling and imaging of lipids on brain and liver tissue by matrix-assisted laser desorption/ ionization mass spectrometry using 2-mercaptobenzothiazole as a matrix. , 2008, Analytical chemistry.

[11]  Amina S Woods,et al.  In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS , 2007, Journal of the American Society for Mass Spectrometry.

[12]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[13]  Jeremy C. Allegood,et al.  Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.

[14]  H. Rosen,et al.  A lipid binding domain in sphingosine kinase 2. , 2009, Biochemical and biophysical research communications.

[15]  T. Hornemann,et al.  The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases* , 2009, The Journal of Biological Chemistry.

[16]  K. Takeda,et al.  Distinctive glycolipid patterns in Wilms' tumor and renal cell carcinoma. , 1991, Cancer letters.

[17]  Richard M Caprioli,et al.  Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation[S] , 2009, Journal of Lipid Research.

[18]  P. Schwartz.  Current diagnosis and treatment modalities for ovarian cancer. , 2002, Cancer treatment and research.

[19]  N. Callewaert,et al.  P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. , 2007, Glycobiology.

[20]  E. L. Kean.  Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. , 1968, Journal of lipid research.

[21]  A. Merrill,et al.  Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. , 2005, Methods.

[22]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[23]  D. Pearl,et al.  Patterns of reactivity with anti‐glycolipid antibodies in human primary brain tumors , 1994, Journal of neuroscience research.

[24]  F. Autschbach,et al.  Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity1 , 2007, The Journal of Immunology.

[25]  R. Kannagi,et al.  Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies. , 1990, Cancer research.

[26]  S. Nozawa,et al.  Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma. , 1992, Cancer research.

[27]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Van Rooijen,et al.  Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. , 2007, Cancer research.

[29]  I. Ishizuka,et al.  Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma , 1996, Cancer.

[30]  F. Hsu,et al.  Studies on sulfatides by quadrupole ion-trap mass spectrometry with electrospray ionization: Structural characterization and the fragmentation processes that include an unusual internal galactose residue loss and the classical charge-remote fragmentation , 2004, Journal of the American Society for Mass Spectrometry.

[31]  Steven C. Lawlor,et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.

[32]  M. Fathalla,et al.  Sulfatides in ovarian tumors: clinicopathological correlates , 2003, International Journal of Gynecologic Cancer.

[33]  G. Jaques,et al.  Re‐assessment of acidic glycosphingolpids in small‐cell‐lung‐cancer tissues and cell lines , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[34]  Shuming Nie,et al.  Nanotechnology for targeted cancer therapy , 2007, Expert review of anticancer therapy.

[35]  Lilya V. Matyunina,et al.  Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells , 2009, BMC Medical Genomics.

[36]  S. Milstien,et al.  Export and functions of sphingosine-1-phosphate. , 2009, Biochimica et biophysica acta.

[37]  Ying Liu,et al.  Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. , 2008, Analytical chemistry.

[38]  A. Merrill,et al.  Two Mammalian Longevity Assurance Gene (LAG1) Family Members, trh1 and trh4, Regulate Dihydroceramide Synthesis Using Different Fatty Acyl-CoA Donors* , 2003, Journal of Biological Chemistry.